3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
34
Carcinoma, Non-Small-Cell Lung
26
Breast Neoplasms
25
Lung Neoplasms
24
Colonic Neoplasms
18
Head and Neck Neoplasms
16
Rectal Neoplasms
14
Sarcoma
10
Prostatic Neoplasms
10
Neoplasm Metastasis
9
Pancreatic Neoplasms
8
Neoplasms
7
Mouth Neoplasms
7
Melanoma
7
Esophageal Neoplasms
7
Ovarian Neoplasms
6
Glioblastoma
6
Adenomatous Polyposis Coli
6
Precancerous Conditions
5
Neuroblastoma
5
Liver Neoplasms
5
Central Nervous System Neoplasms
5
Carcinoma
5
Unspecified Adult Solid Tumor, Protocol Specific
4
Triple Negative Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Recurrence
4
Oropharyngeal Neoplasms
4
Laryngeal Neoplasms
4
Hypopharyngeal Neoplasms
4
Interventions
alvimopan
5
Irinotecan
4
Oxaliplatin
3
Capecitabine
3
Bevacizumab
3
Leucovorin
2
Fluorouracil
2
Cyclophosphamide
2
Cetuximab
2
Aspirin
2
repotrectinib
1
pralsetinib
1
pembrolizumab
1
napabucasin
1
guadecitabine
1
encorafenib
1
alectinib
1
Ursodeoxycholic Acid
1
Surveys and Questionnaires
1
Pemetrexed
1
Oviposition
1
Ocoxin
1
Levoleucovorin
1
KRN-330
1
Folfox protocol
1
Exercise
1
Drug Therapy
1
Drainage
1
Chemoradiotherapy
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Intestinal Diseases
×
Celecoxib
×
Clear all
NCT00808743
2013-05-16
PreDuoFAP
Radboud University Medical Center
Phase 2/3
Completed
37 enrolled